investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Prediction of Treatment-Related Mortality and Therapeutic Resistance in AML
Roland B Walter
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Alan Burnett
Cardiff University
Cardiff, United Kingdom
Bob Lowenberg
Erasmus University Medical Center
Rotterdam, Netherlands
Megan Othus
Fred Hutchinson Cancer Research Center
Seattle, United States
Roland B Walter
Fred Hutchinson Cancer Research Center
Seattle, United States
Related projects
Reuben Kapur
Role of p21 Activated Kinase in Leukemogenesis
Leukaemia
Hematology and hematologic malignancies
Richard Aplenc
Toxicity Monitoring on Phase III Trials with Administrative Data
Leukaemia
Hematology and hematologic malignancies
Ronald Hoffman
A New Murine Model for MPN: Pathology and Therapy of NF-E2 Overexpression
Leukaemia
Hematology and hematologic malignancies
Pathology
Jeffrey S Miller
NK Cells, their Receptors and Unrelated Donor Transplant
Leukaemia
Hematology and hematologic malignancies
Pathology
Andrew G Myers
Synthesis and Study of Natural and Non-natural Antiproliferative Agents
Leukaemia
Hematology and hematologic malignancies
Pathology
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Hematology and hematologic malignancies
Pathology
Joseph L Wiemels
Genome-Wide Association Study of Childhood Leukemia by Hispanic Status
Leukaemia
Hematology and hematologic malignancies
David A Fruman
TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance
Leukaemia
Hematology and hematologic malignancies
Pathology
Michele S Redell
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
Leukaemia
Hematology and hematologic malignancies
